Pathogenesis of atopic dermatitis (AD) and the role of allergic factors

European Review for Medical and Pharmacological Sciences

Volumn 5, Issue 3, 2001, Pages 95-117

  Cantani, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Atopic dermatitis; Children; IgE antibodies; Langerhans cells; Preventive measures; Skin immune system; T cells

Indexed keywords

ALLERGEN; CELL ADHESION MOLECULE; CYTOKINE; HOMING RECEPTOR; IMMUNOGLOBULIN E; T LYMPHOCYTE RECEPTOR; UVOMORULIN;

ATOPIC DERMATITIS; ATOPY; CELL ACTIVATION; CELL MATURATION; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; EOSINOPHIL; HEREDITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; KERATINOCYTE; LANGERHANS CELL; LUNG ALVEOLUS CELL; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; SKIN ALLERGY; SKIN CELL; SKIN EPITHELIUM; TH2 CELL;

ALLERGENS; DERMATITIS, ATOPIC; HUMANS; IMMUNOGLOBULIN E; LANGERHANS CELLS; MACROPHAGES; SKIN; TH2 CELLS;

EID: 0035570040     PISSN: 0392291X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (214)

1. The skin as an organ of immunity
2. Cadherins and Langerhans cell immunobiology
3. Immunologic elements of the skin: What are they? What do they do?
4. Mast cell in atopic dermatitis
5. Epidermal mast cells in atopic dermatitis
6. Biological properties of human skin mast cells
7. Eosinophil granule protein inhibit substance P-induced histamine release from human skin mast cells
8. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
9. Human dermal mast cells contain and release tumor necrosis factor a which induces endothelial leukocyte adhesion molecule 1
10. Induction of human IgE synthesis in B cells by mast cells and basophils
11. Role of IgE in atopic dermatitis
12. Histopathological and immunohistological aspects of atopic eczema
13. Pathogenesis of eczema
14. Characterization of infiltrating CD+ cells in atopic dermatitis using CD45R and CD29 monoclonal antibodies
15. Pathogenesis of atopic eczema
16. Lymphocyte homing and homeostasis
17. E-selectin and vascular cell adhesion molecule-1 as critical adhesion molecules for infiltration of T lymphocytes and eosinophils in atopic dermatitis
18. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
19. Skin disease-related T cells bind to endothelial selectins: Expression of cutaneous lymphocyte antigen (CLA) predicts E-selectin but not P-selectin binding
20. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells
21. Primary sensitization to inhalant allergens during infancy
22. Keratinocytes as initiation of inflammation
23. The role of cytokines and neuroendocrine hormones in cutaneous immunity and inflammation
24. Human keratinocytes are a major source of cutaneous platelet-derived growth factor
25. HLA-DR expression is induced in keratinocytes in delayed hypersensitivity but not in allergen induced late-phase reactions
26. Exaggerated and persistent cutaneous delayed-type hypersensitivity in transgenic mice whose epidermal keratinocytes constitutively express B7-1 antigen
27. Eosinophils in atopic dermatitis
28. CD40 ligand is functionally expressed on human eosinophils
29. Skin eosinophilia in atopic patients
30. Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia
31. Role of eosinophils in atopic eczema
32. Human eosinophil cationic proteins (ECP and EPX) and their suppressive effects on lymphocyte proliferation
33. The eosinophils and cutaneous oedema
34. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis: Comparison with onchocerciasis
35. Serum eosinophil cationic protein in patients with atopic dermatitis
36. Stimulation of basophils and rat mast-cell histamine release by eosinophil granule-derived cationic proteins
37. Mechanism of membrane damage mediated by human eosinophil cationic proteins
38. Correlation of eosinophils, eosinophil cationic protein, soluble interleukin-2 receptor with the clinical activity of atopic dermatitis
39. A role for IgE in patch test reactions to inhalant allergens in atopic dermatitis
40. Cellular interactions in atopic dermatitis
41. The Langerhans cell: An underestimated cell in atopic disease
42. Immunologic nature of atopic dermatitis: Implications for new directions in treatment
43. Hyperstimulatory CD1a+CD1b+ CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis
44. Inhibition of epidermal Langerhans cell function by low dose ultraviolet B radiation: Ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans cells
45. Functional expression of the costimulatory molecule B7/BB1 on murine dendritic cell populations
46. In vivo modulation of the high-affinity receptor for IgE (FceRI) on human epidermal Langerhans cells
47. Expression of the high affinity IgE-receptor on human Langerhans' cells
48. Langerhans cell phenotyping: A new tool for differential diagnosis of inflammatory skin diseases
49. Serum-IgE-facilitated allergen presentation in atopic disease
50. Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE
51. The presence of IgE on monocytes/macrophages infiltrating into the skin lesions of atopic dermatitis
52. Human recombinant interleukin 4 induces Fc R2/CD23 on normal human monocytes
53. Regulation of low affinity (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects
54. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: Relationship to eosinophil, T cell, and macrophage recruitment
55. IgE-dependent cytokine production by human peripheral blood mononuclear phagocytes
56. Secretion of leukotriene C and other arachidonic acid metabolites by macrophages challenged with immunoglobulin E immune complexes
57. Circulating IgG antibodies to IgE in atopic syndromes
58. Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate
59. Phenotypic and functional characteristics of in vivo activated Langerhans cells
60. Evidence that cutaneous antigen presenting cells migrate to regional lymph nodes during contact sensitization
61. The ability of cultured Langerhans cells to process and present protein antigens is MHC-dependent
62. Epidermal Langerhans' cells and their function in the skin immune system
63. Polymorphism of transporters associated with antigen processing genes in atopic dermatitis
64. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis
65. The role of eosinophils in the pathogenesis of atopic dermatitis-eosinophil granule proteins as markers of disease activity
66. The role of cytokines in the pathogenesis of atopic dermatitis: A review
67. Human dermal mast cells contain and release tumor necrosis factor a which induces endothelial leukocyte adhesion molecule 1
68. Evidence for compartimentalization of functional subsets of CD4 positive T lymphocytes in atopic patients
69. Human atopen-specific types 1 and 2 T helper cell clones
70. Human sensitization
71. Genetics aspects of atopic eczema
72. HLA and atopic dermatitis with high serum levels
73. Chromosome 11q13 and atopy underlying atopic eczema
74. IgE-mediated allergic reactions to cow's milk
75. Association of HLA-DQ antigen with cow milk protein allergy in Italian children
76. Mite allergy, clinical atopy, and restriction by HLA class II immune response genes
77. HLA in eczema and hay fever
78. Association between genetic variants of mast-cell chymase and eczema
79. Association between atopy and variants of the β subunit of the high-affinity immunoglobulin E receptor
80. The association of atopy with a gain-of-function mutation in the a subunit of the interleukin-4 receptor
81. Alleles and aplotypes of the MHC-encoded ABC transporters TAP1 and TAP2 (Erratum)
82. Genetic risk for asthma, allergic rhinitis, and atopic dermatitis
83. Immune dysregulation in atopic eczema
84. Higher risk of infantile atopic dermatitis from maternal atopy than from paternal atopy
85. Eczema in primary immune-deficiencies. Clue to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome
86. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation
87. Genes, environments, and sex: Factors of importance in atopic diseases in 7-9-year-old Swedish twins
88. A prospective study of the clinical manifestations of atopic disease in infancy
89. Perinatal factors influencing the development of allergy
90. The skin immune system: Progress in cutaneous biology
91. T-cell responses in allergic rhinitis, asthma and atopic dermatitis
92. Patients with atopic eczema do become sensitized to contact allergens
93. Long chain fatty acids and atopic dermatitis
94. Changes in cell-mediated immunity in atopic eczema
95. Pathogenesis and management of atopic dermatitis
96. Interleukin-1 is released at sites of human cutaneous allergic reaction
97. Atopic dermatitis: Correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity
98. Th1 and Th2 cells in atopy
99. House dust mite-specific T cells in the skin of subjects with atopic dermatitis: Frequency and lymphokine profile in the allergen patch test
100. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis
101. No relationship between skin-infiltrating Th2-like cells and allergen-specific IgE response in atopic dermatitis
102. Inhalant allergens in the pathogenesis of atopic dermatitis
103. Impairment of the autologous mixed lymphocyte reaction in atopic dermatitis
104. Preferential recruitment of activated, memory T lymphocytes into skin chamber fluids during human cutaneous late-phase allergic reactions
105. Prostaglandin E2 control of T cell cytokine production is functionally related to the reduced lymphocyte proliferation in atopic dermatitis
106. Eicosanoids in skin of patients with atopic dermatitis: Prostaglandin E2 and leukotriene B4 are present in biologically active concentrations
107. Detection of dcreased cytotoxic effector CD8+ lymphocytes in atopic dermatitis by flow cytometry
108. Humoral and cellular immunity in children with active and quiescent atopic dermatitis
109. Infezioni e atopia
110. Selective alterations in natural killer subsets in patients with atopic dermatitis
111. T-lymphocytes and blood eosinophils in early infancy in relation to heredity for allergy and type of feeding
112. Numerical and functional deficiency of suppressor T-cells precedes development of atopic eczema
113. Characterization of infiltrating CD+ cells in atopic dermatitis using CD45R and CD29 monoclonal antibodies
114. Age-related changes in human blood lymphocyte subpopulations
115. Immunology and atopic dermatitis
116. Interferon-g production by cord-blood mononuclear cells is reduced in newborns with a family history of atopic disease and is independent from cord-blood IgE-levels
117. 4 and interferon-g mRNA expression by antigen stimulated lymphocytes at birth
118. Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema?
119. Reduced interferon-g secretion in neonates and subsequent atopy
120. Decreased production of IFNg and increased production of IL-6 by cord blood mononuclear cells of newborns with a high risk of atopy
121. IL-4 inhibits the synthesis of IFN-γ and induces the synthesis of IgE in human mixed lymphocyte cultures
122. Allergen-specific CD4+ T lymphocytes in contact dermatitis and atopic dermatitis
123. The role of cytokines and neuroendocrine hormones in cutaneous immunity and inflammation
124. Down-regulating effects of IL-4 and IL-10 on the IFN-γ response in atopic dermatitis
125. Evidence suggesting involvement of interleukin-4 (IL-4) production in spontaneous IgE synthesis in patients with atopic dermatitis
126. Overexpression of IL-10 in atopic dermatitis: Contrasting cytokine patterns with delayed-type hypersensitivity reactions
127. Mast cell lines produce lymphokines in response to linkage of FceRI to calcium ionophores
128. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis
129. Chronologic analysis of in situ cytokine expression in mite allergen-induced dermatitis in atopic subjects
130. IL-4 and interferon-gamma production in children with atopic disease
131. Spontaneous expression of IL-4 mRNA in lymphocytes from children with atopic dermatitis
132. Immunologic disturbances in cow's milk allergy, 2: Evidence for defective interferon-gamma generation
133. House dust mite-specific T cells in the skin of subjects with atopic dermatitis: Frequency and lymphokine profile in the allergen patch test
134. High frequency of IL-4-producing CD4+ allergen-specific T lympocytes in atopic dermatitis lesional skin
135. No relationship between skin-infiltrating Th2-like cells and allergen-specific IgE response in atopic dermatitis
136. Reduced interferon-gamma (IFN-γ) secretion with increased IFN-γ mRNA expression in atopic dermatitis: Evidence for a post-transcriptional defect
137. IL-18 together with IL-12 inhibits IgE synthesis by induction of IFNg production from activated B cells
138. The role of food hypersensitivity and mediator release in atopic dermatitis
139. Immunologic elements of the skin: What are they? What do they do?
140. Atopic dermatitis in children: An update
141. State of the art: Atopic dermatitis and food allergy: Diagnosis and management in children
142. Atopic dermatitis: Clinical relevance of food hypersensitivity reactions
143. Syndrome Dermorespiratoire
144. Food hypersensitivity and atopic dermatitis: Evaluation of 113 patients
145. E-selectin and vascular cell adhesion molecule-1 as critical adhesion molecules for infiltration of T lymphocytes and eosinophils in atopic dermatitis
146. Presence of IgE antibodies to staphylococcal enterotoxins on the skin of patients with atopic dermatitis: Evidence for a new group of allergens
147. Bacterial infection and atopic eczema
148. Determination of IgE antibodies to Candida albicans mannan with nitrocellulose-RAST in patients with atopic diseases
149. Cutaneous late-phase response in food-allergic children and adolescents with atopic dermatitis
150. Increased plasma histamine concentrations after food challenges in children with atopic dermatitis
151. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity
152. Immunohistochemical studies in mite antigen induced patch test sites in atopic dermatitis
153. Le CD23: Structures, fonctions et perspectives pratiques dans les réactions allergiques
154. Risk of infantile atopic dermatitis from parental atopy
155. Immunodeficienza e dermatite atopica
156. T-cells, cytokines, IgE and allergic inflammation
157. Expression of endothelial-leukocyte adhesion molecule-1 in elicited late phase allergic reactions
158. Migration of skin-homing T cells across cytokine-activated human endothelial cells layers involves cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the cutaneous (LFA-1)
159. Role of eosinophils in atopic eczema
160. Relative contribution of human types 1 and 2 Th (Th1 and Th2) cell-derived eosinophilotropic cytokines in development of eosinophilia
161. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factors, in allergen-induced late-phase cutaneous reactions in atopic subjects
162. Th2 cytokine mRNA expression in skin in cutaneous T cell lymphoma
163. Atopic dermatitis - The skin manifestation of atopy
164. Expression of interleukin-4 and interleukin-5 mRNA in developing cutaneous late-phase reactions
165. Cytokine levels and inflammatory responses in developing late-phase allergic reactions in the skin
166. Ontogeny of human lymphocytes during intrauterine life. I. Phenotypical analysis of T cells
167. Natural history of sensitizations in atopic dermatitis
168. Eosinophils and T-lymphocytes in late-phase allergic reaction
169. Lesional expression of interferon-g in atopic eczema
170. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial Th2 response to a Th1 response in situ: An immunocytochemical study
171. Production and modulation of T-cell cytokines in atopic allergy
172. T cells mediate IL-4 dependent local tissue inflammation
173. The role of T lymphocytes in patients with food-sensitive atopic dermatitis
174. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen
175. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor the cutaneous lymphocyte-associated antigen (CLA)
176. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis
177. Analysis of the cytokine pattern expressed in situ in inhalant patch test reactions of atopic dermatitis patients
178. Down-regulating effects of IL-4 and IL-10 on the IFN-γ response in atopic dermatitis
179. Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations
180. Evidence for a locus regulating total serum IgE level mapping to chromosome 5
181. Allelic association of markers on chromosome 5q and 11q with atopy and bronchial hyperresponsiveness
182. T-cells, cytokines, IgE and allergic inflammation
183. Causation of eczema, urticaria, and angioneurotic edema by proteins other than those derived from foods
184. Role of inhalant allergens in atopic eczema
185. The rate of absorption of ragweed pollen material from the nose
186. Sensitization of saprophytic fungi in a case of eczema
187. Atopic dermatitis. II. Role of the sweating mechanism
188. Studies in atopic dermatitis. IV. Importance of seasonal inhalant allergens, especially ragweed
189. Atopic dermatitis. I. An experimental clinical study of the role of inhalant allergens
190. Studies on hypersensitivity to molds and staphylococci in prurigo Besnier
191. Uber Erfahrungen mit der allergenfreien Kammer nach Strom van Leeuwen: Insbesondere in der Spatperiode der exsudative Diathese
192. Basophils in allergen-induced patch-test sites in atopic dermatitis
193. Eczematous reactions in atopic patients caused by epicutaneous testing with inhalant allergens
194. Challenge reactions in atopic dermatitis after percutaneous entry of mite antigen
195. Atopic dermatitis and aeroallergen contact sensitivity
196. Aeroallergen contact can exacerbate atopic dermatitis: Patch tests as a diagnostic tool
197. The relationship between positive aeroallergen patch test reactions and aeroallergen exacerbation of atopic dermatitis
198. A study of the role of house-dust mite in atopic dermatitis
199. Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema?
200. Role of immediate hypersensitivity in the pathogenesis of atopic dermatitis
201. Comparison of results of skin tests, RAST, and double-blind, placebo-controlled food challenges in children with atopic dermatitis
202. Role of immediate food hypersensitivity in the pathogenesis of atopic dermatitis
203. The role of foods in atopic eczema
204. A controlled trial of oral sodium cromoglycate in atopic eczema
205. Results of a milk and/or egg free diet in children with atopic dermatitis
206. Personal experience on the diagnostic procedures in children with atopic dermatitis and food allergy
207. Natural history of soy antigenicity and or allergenicity in children, and the clinical use of soy-protein formulas
208. Severe reactions to cow's milk in very young infants at risk of atopy
209. Staphylococcal colonization, infection, and atopic dermatitis; association not etiology
210. Atopic dermatitis and staphylococcal superantigens
211. Prevention of atopic disease in at risk newborns
212. Double-blind controlled trial of effect of house-dust-mite allergen avoidance in atopic dermatitis
213. The development of allergy in high-risk children